Angiotensin converting-enzyme inhibitors and candesartan have no effects on atrial fibrillation after cardiac surgery: comment on: Mehmet Ozaydin et al. "Effect of renin-angiotensin aldosterone system blockers on postoperative atrial fibrillation".
The manuscript is a "Letter to the Editor" concerning the paper: "Ozaydin M, Dede O, Varol E, et al. Effect of renin-angiotensin aldosteron system blockers on postoperative atrial fibrillation. Int J Cardiol 2008; 127: 362-367".
Mariscalco
Giovanni
G
Dominici
Carmelo
C
Banach
Maciej
M
Sala
Andrea
A
D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D001562:Benzimidazoles / Q000008:administration & dosage*; D001713:Biphenyl Compounds; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage; D011183:Postoperative Complications / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D011446:Prospective Studies; D012084:Renin-Angiotensin System / Q000187:drug effects* / Q000502:physiology; D013777:Tetrazoles / Q000008:administration & dosage*
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D000451:Mineralocorticoid Receptor Antagonists; D013777:Tetrazoles; C081643:candesartan